Overview
Employees
1-10
Founded date
2008
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 9, 2021 | Recro takes on big brother role with opioid addiction drug maker, handling manufacturing duties and advising on FDA work | Just three weeks ago, CDMO Recro Pharma expanded its footprint to the West Coast, as it acquired San Diego-based Irisys for $50 million cash. The deal helped the company branch out into a broader set of dosage forms — and now th... |
| Sep 1, 2021 | BioCorRx Inc. Receives of Approximately $3.5 Million NIDA Grant for the Clinical Trial of BICX104, Its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder | BioCorRx Inc. announced that it has been awarded approximately $3.5 million for the second phase of a grant which was awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under award numbe... |
| Sep 1, 2021 | BioCorRx : Announces Award of Approximately $3.5 Million NIDA Grant for the Clinical Trial of BICX104, its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder | On track to commence the first-in-human clinical trial for BICX104 ANAHEIM, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatm... |
| Mar 2, 2021 | BioCorRx Completes $2.25 Million Private Placement | ANAHEIM, CA, March 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, today announced that the Company co... |
| Nov 20, 2019 | FDA is urged to probe a Louisiana program for ‘illegally’ testing an addiction treatment on inmates | A consumer advocacy group and more than two dozen academics are demanding regulators investigate Louisiana corrections officials and a small company for testing an implantable version of an addiction treatment on inmates, but without follow... |
| Dec 13, 2018 | «Жидкое золото», искусственная интуиция и цифровая терапевтика. Часть первая | 0 Обсудить 577 просмотров Тогда как одни только сейчас узнают, что такое «цифровая медицина», другие считают, что она уже умерла и вечеринка закончилась. Так, с 2014 года по 2017 год в США в 800 с лишним стартапов было инвестировано около 1... |
Reviews 0
FAQ about BioCorRx, Inc. (BICX)
When was BioCorRx, Inc. (BICX) founded?
BioCorRx, Inc. (BICX) was founded in 2008.
What has the press written about BioCorRx, Inc. (BICX)?
Parsers VC has collected 7 articles mentioning BioCorRx, Inc. (BICX), among them “Recro takes on big brother role with opioid addiction drug maker, handling manufacturing duties and advising on FDA work” (Sep 9, 2021) and “BioCorRx Inc. Receives of Approximately $3.5 Million NIDA Grant for the Clinical Trial of BICX104, Its Implantable Naltrexone Pellet for the Treatment of Opi...” (Sep 1, 2021).
Is BioCorRx, Inc. (BICX) still active?
Yes, BioCorRx, Inc. (BICX) is active; its latest activity on Parsers VC dates from Sep 23, 2022.